Abstract:Background and aim: Immunoglobulin A nephropathy (IgAN) is regarded as the most common type of glomerulonephritis around the world and has the potential to result in renal failure. Complement activation has been addressed by a great body of evidence in the pathogenesis of IgAN. We aimed to evaluate the predictive value of C3 and C1q deposition for disease progression in IgAN patients in this retrospective study. Methods: We recruited 1191 biopsy-diagnosed IgAN patients, and they were divided into different groups according to their glomerular immunofluorescence examination of renal biopsy tissues: 1) C3 deposits ≥ 2 + group (N = 518) and C3 deposits < 2 + group (N = 673). 2) C1q deposit-positive group (N = 109) and C1q deposit-negative group (N = 1082). The renal outcomes were end-stage renal disease (ESRD) and/or an estimated glomerular filtration rate (eGFR) decrease greater than 50% from the baseline value. Kaplan-Meier analyses were performed to evaluate renal survival. Univariate and multivariate Cox proportional hazard regression models were used to evaluate the effect of C3 and C1q deposition on renal outcome in IgAN patients. In addition, we compared the predictive value of mesangial C3 and C1q deposition in IgAN patients. Results: The median follow-up period was 53 months (interquartile range 36-75 months). During follow-up, 7% (84) of patients progressed to ESRD, and 9% (111) of patients had an eGFR decline ≥ 50%. IgAN patients complicated with C3 deposits ≥ 2 + were associated with more severe renal dysfunction and pathologic lesions at the time of renal biopsy. The crude incidence rates for the endpoint were 12.5% (84 out of 673) and 17.2% (89 out of 518) in the C3 < 2 + and C3 ≥ 2 + groups, respectively (P = 0.022). Of C1q deposit-positive and C1q deposit-negative patients, 22.9% (25 out of 109) and 13.7% (148 out of 1082) reached the composite endpoint, respectively (P = 0.009). Adding C3 deposition to clinical and pathologic models had better predictability of renal disease progression than C1q. Conclusion: Glomerular C3 and C1q deposits affected the clinicopathologic features of IgAN patients and emerged as independent predictors and risk factors for renal outcomes. In particular, the predictive ability of C3 was slightly better than that of C1q.

Status of Research on Endocapillary Proliferation Lesion in IgA Nephropathy

Clinical Significance and Prognosis of Endocapillary Proliferation in IgA Nephropathy

Clinical and Pathology Features of IgA Nephropathy with Active Tubular Interstitial Lesions

Clinicopathologic features and outcomes in endocapillary proliferative IgA nephropathy.

Clinical and pathological characteristics and prognosis of IgA nephropathy with diffused endocapillary proliferation

IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment

Evaluation Of Crescent Formation As A Predictive Marker In Immunoglobulin A Nephropathy: A Systematic Review And Meta-Analysis

The Role of Immune Modulation in Pathogenesis of IgA Nephropathy

The pathogenesis of IgA nephropathy and implications for treatment

Functional networks of aging markers in the glomeruli of IgA nephropathy: a new therapeutic opportunity.

IgA Nephropathy: Current Treatment and New Insights

Pathogenic Immunoglobulin A-Producing Cells in Immunoglobulin A Nephropathy

IgA Nephropathy: Emerging Mechanisms of Disease

Current understanding and new insights in the treatment of IgA nephropathy

Roles of mesangial C3 and C1q deposition in the clinical manifestations and prognosis of IgAN

[Diagnosis and Treatment of IgA Nephropathy-2023]

Immunoproteasome In Iga Nephropathy: State-Of-Art And Future Perspectives

Clinicopathological Analysis of IgA Nephropathy Combined with Other Glomerular Diseases

Pathological classiifcation and clinical manifestations of 277 patients with IgA nephropathy

The study of the constitution, mucosal inflammation, Chinese medicine syndrome types and clinical pathology in IgA nephropathy

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy